Explore the Possibilities Our proprietary BIOACTIV™ combinatorial biocatalysis technology integrates enzymatic, microbial, and selected chemical transformations to generate highly focused libraries of hundreds or thousands of compounds based on a single lead candidate. Often with amazing chemo-, regio-, and stereo- selectivity. Functionalized derivatives. Metabolites. Small molecule organics. Complex natural products. All delivered
to our customers on 96-well plates ready for highthroughput screening. Just think, rapid access to a diverse array of high-quality test compounds not readily accessible by chemical methods alone. Speed up the derivatization process. Broaden patent coverage. Evaluate novel transformations. Evaluate all of your hits, not just a selected few. The possibilities are endless. But with BIOACTIV™, the discovery and optimization of leads doesn't have to be.
EnzyMed EnzyMed
A Division of Albany Molecular Research, Inc. I Albany Molecular Research, Inc.®
CIRCLE 1 ON READER SERVICE CARD
2501 Crosspark Road, Iowa City, IA 52242 Voice: 319-626-5400 • Fax: 319-626-5410
[email protected] • www. enzy med.com
